Validating thyroid-stimulating hormone (TSH) reflexive testing cutpoints in a tertiary care institution.

Clin Chem Lab Med

Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.

Published: December 2019

Download full-text PDF

Source
http://dx.doi.org/10.1515/cclm-2019-0396DOI Listing

Publication Analysis

Top Keywords

validating thyroid-stimulating
4
thyroid-stimulating hormone
4
hormone tsh
4
tsh reflexive
4
reflexive testing
4
testing cutpoints
4
cutpoints tertiary
4
tertiary care
4
care institution
4
validating
1

Similar Publications

Evaluation of current patient-based real-time quality control in clinical chemistry testing.

Clin Chim Acta

December 2024

Department of Clinical Chemistry, Department of Biochemistry, University of Health Sciences, Bakirköy Dr. Sadi Konuk Training and Research Hospital, İstanbul, Türkiye.

Introduction: To perform simulation studies on patient-based real-time quality control (PBRTQC) for aspartate aminotransferase (AST), iron (Fe), potassium (K), and thyrotropin (thyroid stimulating hormone, TSH) analytes, focusing on optimizing systematic error detection while minimizing data loss.

Methods: Clinical laboratory data for the four analytes were analyzed using various truncation methods. Among these methods, truncation limits corresponding to fixed percentiles (e.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how thyroid hormones may contribute to coronary atherosclerosis, a leading cause of coronary artery disease (CAD).
  • Utilizing large genetic databases, the research examines various thyroid-related disorders and their potential links to coronary atherosclerosis through Mendelian Randomization techniques.
  • Results indicate that conditions like hypothyroidism and Graves' disease increase the risk of coronary atherosclerosis, while no causal relationship was found between certain thyroid hormones (FT4 and TSH) and the disease.
View Article and Find Full Text PDF

Ethnopharmacological Relevance: Hyperthyroidism is a prevalent clinical endocrine disorder. Danggui Liuhuang Decoction (DGLHD), a traditional Chinese herbal medicine formula, has shown potential benefits for patients with hyperthyroidism in recent studies. However, the clinical efficacy and safety of DGLHD have not been systematically evaluated.

View Article and Find Full Text PDF

Objective: To develop and validate a new prediction model based on the Lass-logistic regression with inflammatory serologic markers for the assessment of carotid plaque stability, providing clinicians with a reliable tool for risk stratification and decision-making in the management of carotid artery disease.

Methods: In this study, we retrospectively collected the data of the patients who underwent carotid endarterectomy (CEA) from 2019 to 2023 in Nanjing Drum Tower Hospital. Demographic characteristics, vascular risk factors, and the results of preoperative serum biochemistry were measured and collected.

View Article and Find Full Text PDF

Thyroid-associated ophthalmopathy (TAO), an autoimmune disorder of the retrobulbar tissue, is present in up to 50 percent of Graves's hyperthyroidism patients. Insulin-like growth factor 1 receptor (IGF-1R) has received attention as a target for the development of therapeutic agent for TAO. IGF-1R and TSHR (thyroid stimulating hormone receptor) interact with each other to form a physical or functional complex, further promoting the development of TAO.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!